LASA6.82

Lasa Supergenerics Limited

· Pharma & Health
₹ CrorePeersMANGALAMBIOFILCHEMORTINGLOBEVINEETLABKREBSBIOALPABALPHARMANATCAPSUQMcap ₹34.2 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation10.712.30.0
+ Impairment Loss / (Reversal)0.00.10.0
+ Finance Costs1.92.70.4
+ Interest Income-0.1-0.00.0
+ Other Non-cash Items0.10.00.0
+ Other — Cash Effects are Investing / Financing2.20.00.0
Changes in Working Capital
+ Inventories-5.1-5.59.9
+ Trade Receivables — Current5.32.11.5
+ Other Financial Assets — Current6.79.20.0
+ Other Financial Assets — Non-current-0.10.00.0
+ Other Current Assets0.01.70.0
+ Other Non-current Assets0.0-0.10.0
+ Trade Payables — Current4.6-3.80.0
+ Other Financial Liabilities — Current0.3-2.20.0
+ Other Financial Liabilities — Non-current0.00.00.0
+ Other Current Liabilities0.13.40.0
+ Other Non-current Liabilities0.0-9.80.0
+ Provisions — Current-6.56.50.0
+ Provisions — Non-current1.00.00.0
Cash from Operating Activities
Profit Before Tax (per I/S)-19.1-19.4-34.6-15.5
+ Total Adjustments (incl. Working Capital)21.316.611.8
Cash from Operations (pre-tax)2.1-2.8-22.8
Cash from Operating Activities2.1-2.8-22.8
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)-0.70.00.0
+ Disp of Fixed Assets0.07.80.0
+ Interest Received — Investing0.20.40.0
+ Other Inflows / (Outflows) — Investing-1.20.00.0
Cash from Investing Activities-0.48.20.0
Cash from Financing Activities
+ Proceeds from Other Equity Instruments0.01.80.0
+ Repayment of Borrowings0.05.30.0
+ Interest Paid1.92.70.0
+ Other Inflows / (Outflows) — Financing0.00.50.0
Cash from Financing Activities-1.9-5.70.0
Net Changes in Cash (pre-FX)-0.2-0.3-22.8
Net Changes in Cash-0.2-0.3-22.8
Closing Cash0.6
Reference Items
EBITDA2.26.3-28.4-8.7
EBITDA Margin %2.084.40-112.98-137.17
Free Cash Flow (CFO − Capex)2.8-2.8-22.8-22.8
Free Cash Flow to Equity-25.0-15.6
Free Cash Flow per Basic Share0.56-0.56-4.56-4.56
Cash Flow to Net Income-0.100.190.67
Cash Paid for Interest1.92.70.0
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.